InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Apollomics Inc.

APLM Clue Score38
United States Fiscal year ends December CIK 0001944885
$21.50 -1.29% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $21.50 +720.61% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 26 Nov 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.0Net income−74.8EPS, diluted−0.21Fiscal year 2021Revenue0.0Net income−94.8EPS, diluted−3.37Fiscal year 2022Revenue0.0Operating income1.0Net income−240.8EPS, diluted−844.95Fiscal year 2023Revenue0.0Net income−172.6EPS, diluted−231.99Fiscal year 2024Revenue0.0Net income−53.9EPS, diluted−52.80
FY2020FY2021FY2022FY2023FY2024
Revenue 0.0 0.0 0.0 0.0 0.0
Growth
Operating income n/a n/a 1.0 n/a n/a
Net income −74.8 −94.8 −240.8 −172.6 −53.9
Growth
EPS, diluted −0.21 −3.37 −844.95 −231.99 −52.80

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−35.7Capital expenditure−0.1Free cash flow−35.8Dividends paid0.0Fiscal year 2021Operating cash flow−43.3Capital expenditure−0.1Free cash flow−43.4Dividends paid0.0Fiscal year 2022Operating cash flow−42.8Capital expenditure−0.4Free cash flow−43.2Dividends paid0.0Fiscal year 2023Operating cash flow−43.2Capital expenditure−0.0Free cash flow−43.2Dividends paid0.0Fiscal year 2024Operating cash flow−28.7Capital expenditure−0.0Free cash flow−28.8Dividends paid0.0
FY2020FY2021FY2022FY2023FY2024
Operating cash flow −35.7 −43.3 −42.8 −43.2 −28.7
Capital expenditure −0.1 −0.1 −0.4 −0.0 −0.0
Free cash flow −35.8 −43.4 −43.2 −43.2 −28.8
Growth
Dividends paid 0.0 0.0 0.0 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash130.6Shareholders’ equity−127.9Fiscal year 2021Cash46.7Shareholders’ equity−212.9Fiscal year 2022Cash32.7Shareholders’ equity−448.1Fiscal year 2023Cash32.1Shareholders’ equity41.2Fiscal year 2024Cash9.8Shareholders’ equity4.9
FY2020FY2021FY2022FY2023FY2024
Cash 130.6 46.7 32.7 32.1 9.8
Shareholders’ equity −127.9 −212.9 −448.1 41.2 4.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Returns
n/a n/a n/a −418.6% −1,107.3%
n/a −76.8% −314.9% −311.6% −411.2%
Balance and payout
n/a n/a 586.0% n/a n/a